Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION

Approved

STANDARD

TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION

Novartis Europharm Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 24, 2023
Approval ID: f2e6aa41a1425c23
Company: Novartis Europharm Limited
Type: Standard

Approval Details

Approval Id: f2e6aa41a1425c23
Drug Cima Aemps Name: TRAVATAN 40 MICROGRAMOS/ML COLIRIO EN SOLUCION
Register Number: 01199001IP2
Holder Company Name: Novartis Europharm Limited
Marketing Company Name: Difarmed S.L.
Holder Company Detail Path: /organization/novartis-europharm-limited
Authorization Date: 2023-05-24
Dosage Form: COLIRIO EN SOLUCIÓN
Dose: 40 µg/ml
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Novartis Europharm Limited
Company Detail Path: /organization/novartis-europharm-limited

Company Information

Pharmaceutical Company Name: NOVARTIS EUROPHARM LIMITED
Country Name: United Kingdom
City Name: camberley,country_gb
Address: 200 Frimley Business Park

Active Ingredients

TRAVOPROST

40 µg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 24, 2023

Approval ID

f2e6aa41a1425c23

Type

Standard

Back to CIMA-AEMPS Approvals